Cancer Research AACR Conference on Molecular Diagnostics - 2008  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 52, 5656-5662, October 15, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Benezra, M.
Right arrow Articles by Ben-Sasson, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benezra, M.
Right arrow Articles by Ben-Sasson, S.

Reversal of Basic Fibroblast Growth Factor-mediated Autocrine Cell Transformation by Aromatic Anionic Compounds1

Miriam Benezra, Israel Vlodavsky2, Avner Yayon, Rachel Bar-Shavit, John Regan, Michael Chang and Shmuel Ben-Sasson

Department of Oncology, Hadassah University Hospital, Jerusalem, Israel [M. B., I. V., R. B-S.]; Department of Chemical Immunology, Weizmann Institute of Science, Rehovot, Israel [A. Y.]; Department of Medicinal Chemistry, Rhone-Poulenc Rorer Central Research, King of Prussia, Pennsylvania [J. R., M. C.]; and The Hubert H. Humphrey Center for Experimental Medicine and Cancer Research, the Hebrew University-Hadassah Medical School, Jerusalem, Israel [S. B-S.]

NIH-3T3 cells transfected with basic fibroblast growth factor (bFGF) fused to a signal peptide sequence (spbFGF cells) are transformed in vitro and tumorigenic in vivo. Treatment of spbFGF cells with low and nontoxic concentrations (0.5–2.5 µg/ml) of negatively charged, nonsulfated aromatic compounds (e.g., aurin tricarboxylic acid, 4-hydroxyphenoxyacetic acid) resulted in restoration of their normal proliferative rate, morphological appearance, and adhesion properties. Binding and cross-linking experiments using 125I-labeled bFGF revealed that these alterations were associated with an up-regulation of high affinity receptors for bFGF on the cell surface. A similar up-regulation of cross-linkable bFGF receptors was induced by these compounds in spbFGF cells that were seeded on fibronectin to enforce a firm cell attachment and flattening. Thus, induction of spbFGF cell adhesion and spreading may not be related to restoration of normal bFGF-receptor interactions. Although the negatively charged aromatic compounds mimic many of the effects of heparin in other systems (e.g., release of heparin- and heparan sulfate-bound proteins, inhibition of heparanase), heparin, heparan sulfate, and dextran sulfate were not effective at the low concentrations of the anionic compounds used in the present study. Likewise, suramin, a sulfated aromatic molecule, was effective at toxic concentrations, 400–600-fold higher than the nonsulfated aromatic compounds. The development of defined, nontoxic anionic compounds may provide a new strategy to interfere with the autonomous and anchorage independent mode of cell growth involved in autocrine cell transformation and cancer.

1 This work was supported by USPHS Grant CA-30289 awarded to I. V. by the National Cancer Institute, Department of Health and Human Services, and by a grant from Rhone-Poulenc Rorer Pharmaceuticals, Inc.

2 To whom requests for reprints should be addressed, at Department of Oncology, Hadassah Hospital, P.O. Box 12000, Jerusalem 91120, Israel.

Received 4/ 8/92. Accepted 8/ 3/92.




This article has been cited by other articles:


Home page
CirculationHome page
B. Medalion, G. Merin, H. Aingorn, H.-Q. Miao, A. Nagler, A. Elami, R. Ishai-Michaeli, and I. Vlodavsky
Endogenous Basic Fibroblast Growth Factor Displaced by Heparin From the Lumenal Surface of Human Blood Vessels Is Preferentially Sequestered by Injured Regions of the Vessel Wall
Circulation, April 1, 1997; 95(7): 1853 - 1862.
[Abstract] [Full Text]


Home page
Journal of Bioactive and Compatible PolymersHome page
J. R. Regan, J. G. Bruno, M. N. Chang, R. Sabatino, R. D'Alisa, S. A. Ben-Sasson, and D. Eilat
Mimicry of Biological Macromolecules by Polyaromatic Anionic Compounds
Journal of Bioactive and Compatible Polymers, January 1, 1993; 8(4): 317 - 337.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1992 by the American Association for Cancer Research.